Fernando L‐López

594 total citations
22 papers, 456 citations indexed

About

Fernando L‐López is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Fernando L‐López has authored 22 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Epidemiology. Recurrent topics in Fernando L‐López's work include Metabolism, Diabetes, and Cancer (6 papers), Pituitary Gland Disorders and Treatments (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Fernando L‐López is often cited by papers focused on Metabolism, Diabetes, and Cancer (6 papers), Pituitary Gland Disorders and Treatments (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Fernando L‐López collaborates with scholars based in Spain, United States and Italy. Fernando L‐López's co-authors include Raúl M. Luque, Manuel D. Gahete, Justo P. Castaño, André Sarmento‐Cabral, Sergio Pedraza‐Arévalo, Juan M. Jiménez‐Vacas, Rafael Sánchez‐Sánchez, Aura D. Herrera‐Martínez, María Ángeles Gálvez-Moreno and Alejandro Ibáñez‐Costa and has published in prestigious journals such as Brain, The Journal of Clinical Endocrinology & Metabolism and The FASEB Journal.

In The Last Decade

Fernando L‐López

22 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fernando L‐López Spain	13	276	132	110	74	73	22	456
Sergio Pedraza‐Arévalo Spain	12	208 0.8×	87 0.7×	143 1.3×	66 0.9×	61 0.8×	25	419
Antonio C. Fuentes-Fayos Spain	14	335 1.2×	163 1.2×	94 0.9×	79 1.1×	109 1.5×	34	547
Stéphanie Lacomme France	9	153 0.6×	80 0.6×	64 0.6×	55 0.7×	71 1.0×	21	367
Esther Rivero‐Cortés Spain	9	110 0.4×	39 0.3×	127 1.2×	29 0.4×	176 2.4×	9	321
Fengjiao Huang China	12	167 0.6×	88 0.7×	41 0.4×	49 0.7×	251 3.4×	27	546
Jung Uee Lee South Korea	10	271 1.0×	121 0.9×	99 0.9×	50 0.7×	80 1.1×	19	541
Ilaria Grossi Italy	12	333 1.2×	264 2.0×	68 0.6×	26 0.4×	22 0.3×	20	473
Naoko Iwasa Japan	4	167 0.6×	35 0.3×	31 0.3×	80 1.1×	24 0.3×	7	415
Jiangang Yu China	14	166 0.6×	81 0.6×	32 0.3×	56 0.8×	16 0.2×	23	386

Countries citing papers authored by Fernando L‐López

Since Specialization

Citations

This map shows the geographic impact of Fernando L‐López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando L‐López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando L‐López more than expected).

Fields of papers citing papers by Fernando L‐López

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando L‐López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando L‐López. The network helps show where Fernando L‐López may publish in the future.

Co-authorship network of co-authors of Fernando L‐López

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando L‐López. A scholar is included among the top collaborators of Fernando L‐López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando L‐López. Fernando L‐López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

L‐López, Fernando, et al.. (2022). Morphofunctional and Molecular Assessment of Nutritional Status in Head and Neck Cancer Patients Undergoing Systemic Treatment: Role of Inflammasome in Clinical Nutrition. Cancers. 14(3). 494–494. 13 indexed citations

Herrero‐Aguayo, Vicente, Juan L López-Cánovas, Fernando L‐López, et al.. (2021). Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic Disease. The Journal of Clinical Endocrinology & Metabolism. 106(12). e4917–e4934. 8 indexed citations

Fuentes-Fayos, Antonio C., Mari C. Vázquez‐Borrego, Juan M. Jiménez‐Vacas, et al.. (2020). Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3. Brain. 143(11). 3273–3293. 56 indexed citations

Vázquez‐Borrego, Mari C., Antonio C. Fuentes-Fayos, Aura D. Herrera‐Martínez, et al.. (2020). Statins Directly Regulate Pituitary Cell Function and Exert Antitumor Effects in Pituitary Tumors. Neuroendocrinology. 110(11-12). 1028–1041. 15 indexed citations

López-Cánovas, Juan L, Mercedes del Río-Moreno, Juan M. Jiménez‐Vacas, et al.. (2020). Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma. Cancer Letters. 496. 72–83. 53 indexed citations

Gómez‐Gómez, Enrique, Juan M. Jiménez‐Vacas, Sergio Pedraza‐Arévalo, et al.. (2019). Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer. Journal of Clinical Medicine. 8(9). 1400–1400. 12 indexed citations

Vázquez‐Borrego, Mari C., Antonio C. Fuentes-Fayos, Aura D. Herrera‐Martínez, et al.. (2019). Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms. The Journal of Clinical Endocrinology & Metabolism. 104(8). 3501–3513. 32 indexed citations

Vázquez‐Borrego, Mari C., Fernando L‐López, María Ángeles Gálvez-Moreno, et al.. (2019). A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells. Neuroendocrinology. 110(1-2). 70–82. 18 indexed citations

Herrera‐Martínez, Aura D., Mari C. Vázquez‐Borrego, Antonio C. Fuentes-Fayos, et al.. (2019). Biguanides exert antitumoral actions in pituitary tumor cells through AMPK-dependent and -independent mechanisms. Endocrine Abstracts. 1 indexed citations

10.

Jiménez‐Vacas, Juan M., Enrique Gómez‐Gómez, Vicente Herrero‐Aguayo, et al.. (2019). Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer. Journal of Clinical Medicine. 8(12). 2056–2056. 11 indexed citations

11.

Herrera‐Martínez, Aura D., Sergio Pedraza‐Arévalo, Fernando L‐López, et al.. (2018). Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?. The Journal of Clinical Endocrinology & Metabolism. 104(1). 57–73. 41 indexed citations

12.

L‐López, Fernando, Emilia Alors‐Pérez, André Sarmento‐Cabral, et al.. (2018). Obesity is associated with a dysregulation in the splicing machinery components at the hepatic level: influence of metformin. Endocrine Abstracts. 1 indexed citations

13.

Sarmento‐Cabral, André, Fernando L‐López, Manuel D. Gahete, Justo P. Castaño, & Raúl M. Luque. (2017). Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways. Molecular Cancer Research. 15(7). 862–874. 31 indexed citations

14.

Hormaechea‐Agulla, Daniel, Manuel D. Gahete, Juan M. Jiménez‐Vacas, et al.. (2017). The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness. Molecular Cancer. 16(1). 146–146. 38 indexed citations

15.

Sarmento‐Cabral, André, Fernando L‐López, & Raúl M. Luque. (2017). Adipokines and Their Receptors Are Widely Expressed and Distinctly Regulated by the Metabolic Environment in the Prostate of Male Mice: Direct Role Under Normal and Tumoral Conditions. Endocrinology. 158(10). 3540–3552. 11 indexed citations

16.

L‐López, Fernando, André Sarmento‐Cabral, Vicente Herrero‐Aguayo, et al.. (2017). Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1. Journal of Cellular and Molecular Medicine. 21(9). 1893–1904. 21 indexed citations

17.

Luque, Raúl M., Fernando L‐López, Rafael Sánchez‐Sánchez, et al.. (2016). Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode. Breast Cancer Research. 18(1). 29–29. 8 indexed citations

18.

Hormaechea‐Agulla, Daniel, Enrique Gómez‐Gómez, Alejandro Ibáñez‐Costa, et al.. (2016). Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker. Cancer Letters. 383(1). 125–134. 29 indexed citations

19.

Abad, Atzel Cândido Acosta, et al.. (2012). Polimorfismo genético en los receptores de la hormona del crecimiento y prolactina en el Siboney de Cuba: Desarrollo de metodologías. Revista de salud animal. 34(2). 109–114. 1 indexed citations

20.

L‐López, Fernando, Mark D. Gonzalez, & E. Aguilar. (1986). Gh response to GRF 1–29: Effects of age, sex, cycle phase and testosterone pretreatment. Journal of Steroid Biochemistry. 25. 81–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact